(6) primary study focus
3.4 Lung diseases At present, most of the treatment of lung diseases lacks specific drugs, it is very important to find suitable and safe drugs for lung disease
This is the first study to directly demonstrate reduced GABA receptor availability in human FXS patients, supporting the hypothesis that GABA receptors could be a potential target for FXS drug therapy (128)
This is why JHU joined The Climate Registryto become part of a network of industries working together around climate action and data integrity and to leverage TCRs expertise and guidance on complex accounting standards. Agathe Pierot, Sustainability Manager, Climate Action, Johns Hopkins University Office of Climate & Sustainability The Johns Hopkins University (JHU) Recognition Tier: Champion TCR Member since 2021 Based in Baltimore, Maryland, Johns Hopkins University (JHU) is making strides in its efforts to achieve net-zero Scope 1 and Scope 2 emissions by 2040, as set forth in the universitys comprehensive Climate Action and Sustainability Plan
Cc thnh phn t nhin trong kem dng m bo tnh an ton v lnh tnh, gip da lun c cung cp m hon ho v dng cht cn thit, mang li ln da mm mi, mn mng v khe khon
However, the independent 2021 replication by Sun et al